DT, B., C, R., KJ, S., AM, S., AE, S., Jr, M. D., . . . EJ, R. (2015). A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001. International journal of clinical oncology, 20(4), 650. https://doi.org/10.1007/s10147-014-0769-0
Chicago Style (17th ed.) CitationDT, Blumenthal, et al. "A Phase III Study of Radiation Therapy (RT) and O⁶-benzylguanine + BCNU Versus RT and BCNU Alone and Methylation Status in Newly Diagnosed Glioblastoma and Gliosarcoma: Southwest Oncology Group (SWOG) Study S0001." International Journal of Clinical Oncology 20, no. 4 (2015): 650. https://doi.org/10.1007/s10147-014-0769-0.
MLA (9th ed.) CitationDT, Blumenthal, et al. "A Phase III Study of Radiation Therapy (RT) and O⁶-benzylguanine + BCNU Versus RT and BCNU Alone and Methylation Status in Newly Diagnosed Glioblastoma and Gliosarcoma: Southwest Oncology Group (SWOG) Study S0001." International Journal of Clinical Oncology, vol. 20, no. 4, 2015, p. 650, https://doi.org/10.1007/s10147-014-0769-0.